USPTO 2015–2025 USPTO PatentsView US Corporation

Abbott Laboratories

USPTO PatentsView assignee record - 485 granted patents across 74 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

485

Total patents granted

CPC technology areas

15.8

Avg claims per patent

-38%

5-year filing velocity

The verdict

Abbott holds 485 US patents across 74 technology areas, rank #917 of 50,000 tracked assignees.

#917
of 50,000 US assignees by volume: Top 4%
by Innovation Score (59.3/100): 15.8
avg claims per patent: -38%
filing velocity, last 5 yrs

Portfolio overview

Abbott Laboratories has been granted 485 US utility patents between 2015 and 2025, placing Abbott Laboratories at rank #917 across all assignees tracked by PlainPatent. This portfolio spans 74 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Abbott Laboratories is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Abbott sits between Tyco Electronics (shanghai) Co., Ltd. (489 patents, rank #913) and Tokyo OHKA Kogyo Co., Ltd. (484 patents, rank #921) - the closest US assignees by grant volume. The composite Innovation Score of 59.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 186 grants, compared with 299 in the 2015–2019 window, a -38% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abbott Laboratories's 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 74 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abbott Laboratories against peers pursuing similar technology classes.

Tyco (Shanghai)

489
Wistron Neweb

489
Biomet Manufactur…

488
University-indust…

488
Bridgestone Ameri…

485
Johnson & Johnson…

485
Abbott Laboratori… ◀

485
Rhodia Operations

484
Tokyo OHKA Kogyo

484

What this shows Abbott holds 485 patents at rank #917, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #917 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Abbott's primary technology class.

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abbott Laboratories patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	52	10.7%
2016	57	11.8%
2017	71	14.6%
2018	58	12.0%
2019	61	12.6%
2020	52	10.7%
2021	43	8.9%
2022	32	6.6%
2023	23	4.7%
2024	25	5.2%
2025	11	2.3%

Which technologies does Abbott Laboratories patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 200

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 77

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 73

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 73

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 70

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 51

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 48

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 46

C07K - PEPTIDES 23

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 22

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 22

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 21

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 14

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 14

B05D - PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL 13

Top 15 of 74 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#917

Across all tracked assignees

Innovation Score

59.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abbott Laboratories hold?

Abbott Laboratories holds 485 US granted patents filed between 2015 and 2025, spanning 74 technology areas.

What is Abbott Laboratories's Innovation Score?

Abbott Laboratories has an Innovation Score of 59.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abbott Laboratories focus on?

Abbott Laboratories's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 200 patents. The company has filed patents in 74 CPC subclasses total.

Is Abbott Laboratories's patent filing rate increasing or decreasing?

Abbott Laboratories's recent filing velocity is -38% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Abbott Laboratories's patents?

Abbott Laboratories's patents average 15.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Abbott Laboratories patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Abbott's 485 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Abbott ranks #917 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.